Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Arexvy, the First RSV Vaccine for Older Adults, Granted Approval by HSA

Thursday, May 16, 2024

Arexvy the worlds first respiratory syncytial virus vaccine has recently gained approval from the Health Sciences Authority of Singapore for immunizing individuals aged years and above against lower respiratory tract disease caused by RSV This groun...

Zai Lab's Application for Priority Review of Efgartigimod Alfa Injection Accepted for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China

Wednesday, May 15, 2024

Zai Lab Limited has announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted the supplemental Biologics License Application

Everest Medicines Introduces NEFECON® to Mainland China with Commercial Launch and First Prescription

Wednesday, May 15, 2024

Everest Medicines a biopharmaceutical company dedicated to advancing medicines and vaccines has announced the successful launch of NEFECON in China marking a significant advancement

HUTCHMED Commences RAPHAEL Registrational Phase III Trial of HMPL-306 for Chinese Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia

Tuesday, May 14, 2024

HUTCHMED Limited has initiated a Phase III clinical trial for HMPL in Chinese patients with relapsed

Mabwell Updates on Clinical Trial Development of 9MW2821 for Triple-Negative Breast Cancer

Tuesday, May 14, 2024

Mabwell an innovative biopharmaceutical company with a comprehensive industry chain has provided updates on the clinical study progress of its groundbreaking ADC targeting Nectin for triplenegative

Launch of Tiopronin Delayed-Release Tablets with Patient Support for Cystinuria Treatment in the United States

Tuesday, May 14, 2024

Cycle Pharmaceuticals Limited is excited to introduce tiopronin delayedrelease tablets as a treatment option for individuals with cystinuria Tiopronin delayedrelease tablets come in mg and mg doses

Dupixent (Dupilumab) Under FDA Priority Review for Adolescent Chronic Rhinosinusitis with Nasal Polyposis Treatment

Monday, May 13, 2024

Regeneron Pharmaceuticals Inc and Sanofi have shared a significant update regarding the potential treatment of adolescents grappling with inadequately controlled chronic rhinosinusitis

QIAGEN's Syndromic QIAstat-Dx Test Granted FDA Clearance for Rapid and Accurate Respiratory Disease Diagnosis

Monday, May 13, 2024

QIAGEN has announced that the US Food and Drug Administration has approved the clinical use of the QIAstatDx Respiratory Panel Plus for syndromic testing

Arcellx and Kite Continue Progress with Advances in Anito-Cel Multiple Myeloma Program

Friday, May 10, 2024

Arcellx Inc and Kite a Gilead Company have jointly announced significant operational advancements in their collaborative effort on the anitocabtagene autoleucel program for multiple myeloma treatment

SN Bioscience Granted FDA Fast Track Status for Small Cell Lung Cancer Therapy

Friday, May 10, 2024

SN Bioscience Co Ltd under the leadership of CEO Park Younghwan made an announcement on May th regarding the FDAs decision to grant Fast Track Designation for SNB a novel polymer nanoparticle anticancer medication currently undergoing clinical trials...